Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. - Wikidata - wikimedia - TriplyDB

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.

http://www.wikidata.org/entity/Q36924504

about

Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies The Short-Term Effect of Weight Loss Surgery on Volumetric Breast Density and Fibroglandular Volume.Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification Qualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and Abroad Reliability of the percent density in digital mammography with a semi-automated thresholding method.Preventative therapies for healthy women at high risk of breast cancer.Emerging Concepts in Breast Cancer Risk Prediction.Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Breast tissue composition and its dependence on demographic risk factors for breast cancer: non-invasive assessment by time domain diffuse optical spectroscopy.Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast Cancer.One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.Mammographic density and breast cancer in women from high risk families.Determinants of the reliability of ultrasound tomography sound speed estimates as a surrogate for volumetric breast density.Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort Sample size and power determination when limited preliminary information is available Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.Mammographic breast density response to aromatase inhibition.Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial.Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment.Ultrasonographic assessment of breast density.Mammographic density-a review on the current understanding of its association with breast cancer.Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.Breast density predicts endocrine treatment outcome in the adjuvant setting.Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients.Review of quantitative multiscale imaging of breast cancer.Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers.Preventive therapy for breast cancer.Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis

P2860

Q26784486-437FF000-C7BA-4149-B1CB-2796914B022C Q28074177-8A33073C-52C8-4AB2-A6C7-EC30826DAF4F Q30275608-7E2A3E16-7060-45C3-9C62-B04B30A15B66 Q30592796-0B5540EA-81A3-49CC-B09F-3D6E7D5B3848 Q31012975-B286E8D2-936D-496E-AF8A-C293C83D259E Q33850485-022E65BE-5E50-4AF2-A84A-C900D9D3B0DE Q33875832-41673138-0433-4ACA-898A-4868E929CF14 Q34393592-FD0DF9E8-E75B-469B-BEA5-6976DD52756F Q34670325-97123032-68DC-4F78-99B6-548735BA0C92 Q35102667-9F9C7520-A5A0-4F0B-88CA-01C056158D15 Q35115517-60FBB93D-D477-467F-B508-C840486840FE Q35647559-FD9EEECC-FE64-4E35-81E4-0D23A16822A2 Q35674339-1C19B268-98F9-4553-A007-B7ACF248AADE Q35674957-BC7380BC-BA52-4F84-A7AD-C98D563095FF Q35842576-B09030F4-0055-4266-93FF-8D3D056BA218 Q36053352-060A3700-D8EE-4E28-88F2-33E7F12B08B3 Q36336239-F05AA0B9-F218-4E29-B440-4AF48A0FAF8F Q36356575-4C6D65C5-39C4-4779-84B0-16E5C5B0E5C9 Q36463912-BE57EF2C-A510-47DA-8BD1-5C51F3E8D7AC Q36649704-491F2ED9-EF7D-485F-9224-CC1C1A405BA7 Q36778183-0BC89DFA-64FD-4F79-A9A2-4FADA6956F5E Q36950678-C3EE9B3B-4494-484A-BAA1-7F29908D565D Q37081944-FE128EA2-8C1D-43E4-BF5A-837DDA946CA6 Q37130113-BA23D279-D9EC-40A7-9245-E6ABDBB241E3 Q37279259-38F25DB1-E0C8-4EB0-B900-EB3A1CB0BD39 Q37691149-86950312-371A-4CD4-8C63-871F40E6CBCE Q38097368-06F786AB-B632-4085-8A4A-89B149FB7B31 Q38194952-201BC972-5052-4C5B-A211-09C082B4057E Q38821494-9EF4AA24-C9CA-4B11-B730-792A69F1E294 Q38851505-088F8A12-C066-4ABB-884B-3188D23E1D1A Q40440059-FE623A47-79C2-4714-8CE3-79EEE3ABBC30 Q40679633-CF42FE1B-A058-4378-9147-2450423E086D Q43128313-4A3F5A82-6693-4663-A2A6-A9C1E37B2431 Q43411694-C8B68165-8ABC-46D0-98BF-B0C8288C7C56 Q48119396-702C7BC6-DE0F-4127-B1F0-1F9815C17213 Q48854479-43BCA742-ABE6-4828-8641-5CCCDA6CB688 Q54484341-4F9A3112-1ACB-457A-9877-8261F9469536 Q55433591-A737352F-1F65-40B5-A95B-1F69DC28A768 Q57560981-28D3229F-93AE-47B1-8F75-B6055A62AE55

P2860

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.

http://www.wikidata.org/entity/Q36924504

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Breast density change as a pre ...... ceptor positive breast cancer.

@en

type

label

Breast density change as a pre ...... ceptor positive breast cancer.

@en

prefLabel

Breast density change as a pre ...... ceptor positive breast cancer.

@en

P1433

Q36924504-7B361287-86F2-4200-B03D-A431EB057D21

P1476

Q36924504-E779516E-668D-42E3-9EC6-9B2D8911E31C

P2093

Q36924504-624FE834-9129-4D1E-9C61-1A7C43AB3E18

Q36924504-6D57FB5E-B9E3-4F61-A3D9-A52CECE60E9E

Q36924504-707BA790-A220-4188-953C-E1D5B6E7B954

Q36924504-70D2289B-0EE7-4C6F-885A-5E0B2B58C10D

Q36924504-97C977CC-B440-4553-ADC7-F0D2184349D4

Q36924504-ABCABCCE-5912-4CD6-887E-A3EDE36FF689

Q36924504-B7F153BC-CB82-4D05-AB52-0E2148B7CD9D

Q36924504-C35DE29B-47F0-45AB-B7E2-F73668173F0F

Q36924504-C63596AC-7A7E-47E3-B38C-85891DD260D3

Q36924504-D1C82C1C-BDB7-4F15-8076-5BFA974278FB

P2860

Q36924504-1367A74E-6D63-438A-B1FC-8574CC381915

Q36924504-191950C6-F363-4CBA-8AF8-949A19E13B89

Q36924504-1E3471C3-E394-4E99-81D2-5AEC33E978AF

Q36924504-21D16FF6-E029-4E1F-BE30-E78A6676178F

Q36924504-2E5B307A-441E-40F5-B5D5-3D6DEF2011E7

Q36924504-7D838DE3-0EC5-4853-9EDF-5BE0D8621716

Q36924504-A1EFE155-F862-45A3-815F-903D81EAEC4E

Q36924504-A7CEFE59-5F74-411C-A1CF-508A5292CFD3

Q36924504-C8C77CDA-8BC8-453B-9084-5F6DC51D5271

Q36924504-CEDDE9C8-5423-45B3-BFDE-D3288D05A353

P2888

Q36924504-F95D9AB8-18B2-42B4-8A97-ED5267378914

P304

Q36924504-4CC5D9DE-6F78-48F1-AF75-4DE159DF6F10

P31

Q36924504-91B60E3F-8A46-41F5-A4BD-1758FAD50F3C

P356

Q36924504-1E42CB12-A22C-4AC7-A4EB-4051F82C604E

P433

Q36924504-B3C62EEC-BC68-44C4-AFA0-EDBA34F4FD10

P478

Q36924504-757778AE-04D4-4538-8201-FA593A7F544B

P50

Q36924504-4E33EA4F-2304-43B4-884F-73F17359166D

Q36924504-897F13A3-A0C5-4F68-8F56-054E4435640D

Q36924504-D81924FF-6149-4CC8-AC19-682E2337C7C4

P577

Q36924504-D3042402-BBAF-4788-9CF2-0189F2E638B0

P5875

Q36924504-4D4B24A6-2FB0-4C0E-86EC-20C41B39049B

P6179

Q36924504-398BC598-1ABD-4436-9A0A-8B327E4794DB

P698

Q36924504-11F1D6CE-E12B-4B51-A4C7-B7D9D6164517

P932

Q36924504-9E2BCE73-CCF3-454F-93DB-C141B14A1588

P356

P1433

Breast Cancer Research

P1476

Breast density change as a pre ...... ceptor positive breast cancer.

@en

P2093

Hee-Chul Shin

http://www.w3.org/2001/XMLSchema#string

Hye Koo

http://www.w3.org/2001/XMLSchema#string

Jee-Man You

http://www.w3.org/2001/XMLSchema#string

Jisun Kim

http://www.w3.org/2001/XMLSchema#string

Nariya Cho

http://www.w3.org/2001/XMLSchema#string

Sae-Won Han

http://www.w3.org/2001/XMLSchema#string

Seock-Ah Im

http://www.w3.org/2001/XMLSchema#string

Soo Ahn

http://www.w3.org/2001/XMLSchema#string

Tae-You Kim

http://www.w3.org/2001/XMLSchema#string

Wonshik Han

http://www.w3.org/2001/XMLSchema#string

P2860

Independent association of lobular involution and mammographic breast density with breast cancer risk.

Reproductive and Hormonal Factors Associated with Fatty or Dense Breast Patterns among Korean Women.

Endocrine-responsive breast cancer and strategies for combating resistance.

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

Biological determinants of endocrine resistance in breast cancer.

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.

Tamoxifen and breast density in women at increased risk of breast cancer.

Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.

The quantitative analysis of mammographic densities.

Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study

P2888

P304

R102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3221

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Hyeong-Gon Moon

P577

2012-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228439233

http://www.w3.org/2001/XMLSchema#string

P6179

1050919137

http://www.w3.org/2001/XMLSchema#string

P698

22770227

http://www.w3.org/2001/XMLSchema#string

P932

3680951

http://www.w3.org/2001/XMLSchema#string